metabolic tumor volume

You have access
Tumor Asphericity in FDG PET Is an Independent Prognostic Parameter Improving Risk Stratification in Patients with Head and Neck Squamous Cell Carcinoma
Patrick Hausmann, Sebastian Zschaeck, Christian Furth, Pavel Nikulin, Paulina Cegla, Siyer Roohani, Elia Lombardo, Joanna Kazmierska, Nathalie L. Albert, Adrien Holzgreve, Iosif Strouthos, Claus Belka, Guillaume Landry, Witold Cholewinski, Jorg Kotzerke, Michael Baumann, Mechthild Krause, Daniel Zips, Jörg van den Hoff and Frank Hofheinz

Journal of Nuclear Medicine May 1, 2025, 66 (5) 686-691; DOI: https://doi.org/10.2967/jnumed.124.268972
You have access
PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient Cohort
Luca Ceriani, Lisa Milan, Maria Cristina Pirosa, Maurizio Martelli, Teresa Ruberto, Luciano Cascione, Peter W.M. Johnson, Andrew J. Davies, Giovannino Ciccone and Emanuele Zucca

Journal of Nuclear Medicine February 1, 2025, 66 (2) 209-214; DOI: https://doi.org/10.2967/jnumed.124.268874
You have access
International Metabolic Prognostic Index Is Superior to Other Metabolic Tumor Volume–Based Prognostication Methods in a Real-Life Cohort of Diffuse Large B-Cell Lymphoma
Vibeke K.J. Vergote, Gregor Verhoef, Ann Janssens, F.J. Sherida H. Woei-a-jin, Wies Deckers, Annouschka Laenen, Thomas Tousseyn, Daan Dierickx and Christophe M. Deroose

Journal of Nuclear Medicine December 1, 2024, 65 (12) 1876-1883; DOI: https://doi.org/10.2967/jnumed.124.268152
You have access
Prognostic Value of ¹⁸F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen
Laure Michaud, Kurt Bantilan, Audrey Mauguen, Craig H. Moskowitz, Andrew D. Zelenetz and Heiko Schöder

Journal of Nuclear Medicine April 1, 2023, 64 (4) 536-541; DOI: https://doi.org/10.2967/jnumed.122.264740
Open Access
¹⁸F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
Kibrom B. Girum, Louis Rebaud, Anne-Ségolène Cottereau, Michel Meignan, Jérôme Clerc, Laetitia Vercellino, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont and Irène Buvat

Journal of Nuclear Medicine December 1, 2022, 63 (12) 1925-1932; DOI: https://doi.org/10.2967/jnumed.121.263501
You have access
¹⁸F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-Cell Lymphoma: The HOVON-84 Study
Coreline N. Burggraaff, Jakoba J. Eertink, Pieternella J. Lugtenburg, Otto S. Hoekstra, Anne I.J. Arens, Bart de Keizer, Martijn W. Heymans, Bronno van der Holt, Sanne E. Wiegers, Simone Pieplenbosch, Ronald Boellaard, Henrica C.W. de Vet, Josée M. Zijlstra and on behalf of the HOVON Imaging Working Group and the HOVON Lymphoma Working Group

Journal of Nuclear Medicine July 1, 2022, 63 (7) 1001-1007; DOI: https://doi.org/10.2967/jnumed.121.262205
You have access
Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at Interim ¹⁸F-FDG PET in Diffuse Large B-Cell Lymphoma
Gerben J.C. Zwezerijnen, Jakoba J. Eertink, Coreline N. Burggraaff, Sanne E. Wiegers, Ekhlas A.I.N. Shaban, Simone Pieplenbosch, Daniela E. Oprea-Lager, Pieternella J. Lugtenburg, Otto S. Hoekstra, Henrica C.W. de Vet, Josee M. Zijlstra and Ronald Boellaard

Journal of Nuclear Medicine November 1, 2021, 62 (11) 1531-1536; DOI: https://doi.org/10.2967/jnumed.120.258673
You have access
Early Treatment Response Assessment Using ¹⁸F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy
Garry Ceccon, Philipp Lohmann, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Gabriele Stoffels, Jurij Rosen, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Niklas Schäfer, Nadim J. Shah, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks

Journal of Nuclear Medicine July 1, 2021, 62 (7) 918-925; DOI: https://doi.org/10.2967/jnumed.120.254243
You have access
Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium
Sally F. Barrington, Ben G.J.C. Zwezerijnen, Henrica C.W. de Vet, Martijn W. Heymans, N. George Mikhaeel, Coreline N. Burggraaff, Jakoba J. Eertink, Lucy C. Pike, Otto S. Hoekstra, Josée M. Zijlstra and Ronald Boellaard

Journal of Nuclear Medicine March 1, 2021, 62 (3) 332-337; DOI: https://doi.org/10.2967/jnumed.119.238923
Open Access
Deep-Learning ¹⁸F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma
Nicolò Capobianco, Michel Meignan, Anne-Ségolène Cottereau, Laetitia Vercellino, Ludovic Sibille, Bruce Spottiswoode, Sven Zuehlsdorff, Olivier Casasnovas, Catherine Thieblemont and Irène Buvat

Journal of Nuclear Medicine January 1, 2021, 62 (1) 30-36; DOI: https://doi.org/10.2967/jnumed.120.242412

Main menu

User menu

Search

metabolic tumor volume

Pages